Recent Updates
Recently added Catalysts
VALN Positive Sentiment

Valneva France Highlights Travel Medicine at the SMV Congress

Key Takeaway: Valneva France participated in the SMV Congress in Paris, focusing on travel medicine. The event attracted 130 participants from travel health clinics, featuring two stands for medical inquiries and product information. Presentations included discussions on chikungunya vaccines and health risks related to the upcoming Paris 2024 Olympic Games.
Price reaction · baseline $7.69 (2024-04-29 close) · hit pre-market · clean, no other VALN news in the window
day 0 close · peak
-3.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Valneva showcased its commitment to travel medicine.
  • The event facilitated important discussions on chikungunya.
  • Valneva's participation highlights its active role in public health.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+97%
120-day peak, hindsight
Typical move
7%
average across 2 past catalysts
Lead asset
VLA2001
Phase 3 · SARS-CoV-2 Virus Infection

Full Press Release Details

Back to Stories
France

Valneva France Highlights Travel Medicine at the SMV Congress

Author: Valneva France
• Share This Story
Share This Story
April marks the start of our French medical and commercial colleagues’ conference season, with the SMV Congress in Paris at the beginning of the month.
The SMV Congress brought together 130 participants representing travel health clinics from around the country. Valneva France had two exposition spaces at the event: a medical stand to handle questions about chikungunya and a commercial stand providing information about our products that are currently available in France.
In addition to the stands, Valneva organized presentations related to chikungunya delivered by doctors, including:
• “Which vaccines for Latin America? Old and New” by Dr. Oula Itani, which ended with a special mention of a promising vaccine in development in Brazil, and
• “Travel Health News. Reminder: Risks of arboviral emergence and reinforcement of health monitoring around the Paris 2024 Olympic and Paralympic Games” by Dr. Arnaud Tarantola.

More Stories

See All Stories

Making Sustainability Durable: Why Governance Matters in Healthcare

Why Prevention Must be at the Center of the Lyme Disease Response

Leadership

Opportunities and Challenges of Being a Dual-Listed Company

Frequently Asked Questions

What was the focus of Valneva at the SMV Congress?

Valneva focused on travel medicine, particularly chikungunya.

How many participants attended the SMV Congress?

The SMV Congress attracted 130 participants from travel health clinics.

What presentations were made at the event?

Presentations included topics on chikungunya vaccines and health risks for the Paris 2024 Olympics.

Where was the SMV Congress held?

The SMV Congress took place in Paris, France.

Last updated: Apr 30, 2024